Get 20% Free Customization In This Report

Buy this report from - $3456

Proton Therapy Market by Application (Prostate Cancer, Breast Cancer, Lung Cancer, Pediatric Conditions) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Healthcare	LI_18529	Pages: NA	May 2018 \| 1851 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Proton therapy is the most precise and advanced form of radiation therapy and is mainly used in the treatment of cancer. It offers significant benefits over conventional radiation therapy in terms of efficacy and limited side effects. It is a painless, non-invasive treatment that maintains the quality of life of patients and enables them to quickly resume normal activities. It allows physicians to deliver full or higher treatment dosages that destroy the main tumor site without causing harm to surrounding healthy tissue or organs. According to The National Association for Proton Therapy, there are 25 centres and 11 centres are under construction in U.S. providing proton therapy treatment across the United States, including UC Davis Crocker Lab, Indiana University Health Proton Therapy Center and M.D. Anderson Cancer Center; 8 new centers are being developed. Till date, more than 80,000 patients suffering from a variety of cancers, such as prostate cancer and brain tumors, have been treated using proton therapy. The demand for this form of treatment is expected to skyrocket as an increasing number of medical professionals and patients are eager to know more about the proton therapy treatment process. The rising number of cancer patients, and the growing global recognition of proton therapy and its benefits drive the growth of this market. Ion Beam Applications, Hitachi, Fermilab Scientists and Varian Medical Systems are the key players in the proton therapy market.

The proton therapy market is segmented into application and geography. On the basis of application, the market is segmented into prostate cancer, breast cancer, lung cancer, pediatric conditions and others. Geographically, the market is segmented into North America, Europe, Asia Pacific and LAMEA.

Key Benefits:

This report provides an in-depth analysis of the proton therapy market with current trends and estimations through 2012-2020.
Geographic analysis of the market would help companies to plan their strategies accordingly and take region specific decisions
Analysis of key strategies adopted by market players would provide market intelligence and help stakeholders understand the competitive structure of the market
The report analyzes market conditions in a comprehensive and quantitative manner and forecasts market trends and techniques for proton therapy applications.

Key Market Segments

Market by Application

Prostate Cancer
Breast Cancer
Lung Cancer
Pediatric Conditions
Others

Market by Geography

North America
Europe
Asia Pacific
LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL PROTON THERAPY MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PROSTATE CANCER

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. BREAST CANCER

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. LUNG CANCER

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. OTHERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 GLOBAL PROTON THERAPY MARKET, BY REGION

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.2.4. North America Proton Therapy Market by Application

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.5. Rest of Europe market size and forecast

5.3.4. Europe Proton Therapy Market by Application

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Australia market size and forecast
5.4.3.4. India market size and forecast
5.4.3.5. Rest of Asia-Pacific market size and forecast

5.4.4. Asia-Pacific Proton Therapy Market by Application

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.2. Saudi Arabia market size and forecast
5.5.3.3. Argentina market size and forecast
5.5.3.4. South Africa market size and forecast
5.5.3.5. Rest of LAMEA market size and forecast

5.5.4. LAMEA Proton Therapy Market by Application

Chapter: 9 COMPANY PROFILES

9.1. ION BEAM APPLICATIONS

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. VARIAN MEDICAL SYSTEMS

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. HITACHI LTD.

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. MITSUBISHI ELECTRIC CORPORATION

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. MEVION MEDICAL SYSTEMS

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.5. OPTIVUS PROTON THERAPY INC.

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.7. PRONOVA SOLUTIONS LLC.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. SAH GLOBAL LLC.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. SUMITOMO CORPORATION

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.